Oneview Healthcare (ASX:ONE) Shares Slide as Its Epic MyChart Bedside Hub Waits for a First Contract

Aditi Sarkar

27 July 2026 08:51 PM AEST

Oneview Healthcare (ASX:ONE) Shares Slide as Its Epic MyChart Bedside Hub Waits for a First Contract

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

FY25 revenue rose 21 per cent to 12.0 million euros, but recurring revenue grew only 7 per cent while hardware and services jumped 60 per cent.

Bedside Hub, which hosts Epic's MyChart Bedside TV, is a hardware and device-management offer rather than a certified Epic partnership, and no revenue or signed contract has been attributed to it.

The CDIs traded near AUD 0.15 on 27 July 2026, down about 12 per cent and below the AUD 0.19 March placement price, with nothing lodged since 9 July to explain the move.

The ONE share-price response remains tied to whether reported growth and strategic initiatives translate into sustained financial delivery.

Oneview Healthcare calls Bedside Hub a material new revenue channel, but no contract is signed. We check FY25 euros, cash burn and the ASX:ONE share slide. The supplied article examines the gap between operating developments and the company’s recent market performance.

The latest financial and market picture

An unflagged announcement with a big claim

A one-page release the exchange did not mark price sensitive is an unusual place to find a company's next growth engine. That is where Oneview Healthcare put it. On 15 May 2026 the Irish-domiciled, ASX-listed patient-engagement software group lodged an announcement titled Oneview's New Revenue Channel, and five days later published the detail: a product called Bedside Hub, built to run Epic's MyChart Bedside TV application on Oneview's own healthcare-grade screens and cloud device management.

Growth initiatives and operating context

The framing is bold. Oneview describes Bedside Hub as an extension of its core platform and, in its own words, a material new revenue channel. What it does not describe is a contract. There is no dollar figure, no named hospital and no disclosed pricing anywhere in the release. Set against a share price that has more than halved from its twelve-month high, the gap between claim and evidence is the whole investment question.

What Oneview actually sells, and in what currency

What still needs to be demonstrated

Oneview builds the software layer between a hospital patient and the systems around them: the bedside screen, entertainment and education content, meal ordering, nurse call routing and the virtual-care video session. It is deployed across more than 80 hospitals, with the United States by far its largest market.

One point matters before any figure is quoted. Oneview reports in euros, and its balance date is 31 December, not 30 June. The most recent full year as at 27 July 2026 is therefore FY25, released as a preliminary final report on 12 February 2026, then an annual report in March and a March-quarter Appendix 4C on 27 April. The June-quarter 4C, due by 31 July 2026, had not been lodged.

About Oneview Healthcare

Oneview Healthcare operates within the healthcare sector. Its current position is assessed through the financial, operating and strategic information contained in the supplied article.

What Investors May Watch Next

Revenue and recurring-income performance

Commercial adoption and contract conversion

Cash use, funding and product execution

Upcoming disclosures and the ONE share-price response

Risks

The company faces commercialisation, contract, technology, healthcare procurement, funding, execution and valuation risks. Forecasts, partnerships and management targets may not produce the expected financial outcome. The supplied information is a point-in-time summary and does not establish future share-price performance.

FAQs

Q: What is the main development at Oneview Healthcare?

A:Oneview Healthcare calls Bedside Hub a material new revenue channel, but no contract is signed. We check FY25 euros, cash burn and the ASX:ONE share slide.

Q: What is a key financial or operating figure?

A:FY25 revenue rose 21 per cent to 12.0 million euros, but recurring revenue grew only 7 per cent while hardware and services jumped 60 per cent.

Q: What is the principal issue to monitor?

A:The CDIs traded near AUD 0.15 on 27 July 2026, down about 12 per cent and below the AUD 0.19 March placement price, with nothing lodged since 9 July to explain the move.

Q: What may influence the ONE share price?

A:Financial delivery, cash generation, execution of the initiatives described in the article and broader sector conditions may influence the ONE share price.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.